We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Apple Faces Lawsuit for Alleged Violation of Masimo Patents
Read MoreHide Full Article
Apple (AAPL - Free Report) is facing a lawsuit for health monitoring features of Apple Watch, per a recent Bloomberg report.
Masimo and its subsidiary Cercacor have accused Apple of unduly exploiting their trademark technology in Apple Watch products, mainly to overcome performance issues.
Lodged with the U.S. District Court for the Central District of California, the suit alleges that Apple Watch, including the latest Apple Watch Series 4 and Series 5 models, leveraged technology covered by 10 Masimo patents. Apple has been accused of multiple infringements in these 10 different patents.
Notable among these is intellectual property detailing Apple Watch’s blood oxygen monitoring system and heart rate detection through light emitters. Masimo wishes to prevent any further usage of its patented inventions.
Apple has also been accused of hiring employees of Masimo for its own advantage, including former executive vice president of Medical Affairs Michael O’Reilly and Cercacor CTO, Marcelo Malini Lamego. Notably, Michael O’Reilly is currently the vice president of Apple’s health technology department.
The news comes at a time when Apple’s smartwatches are witnessing increased adoption in the market. Notably, per Strategy Analytics data, 6.8 million smartwatches were shipped by the company in third-quarter 2019, up 51% from the year-ago quarter figure of 4.5 million units.
Apple has been increasingly facing antitrust investigations and lawsuits over patents, user privacy and App Store-related lawsuits among others.
Last month, the tech giant was sued by a New York University cardiologist over Apple Watch’s use of his patented heartbeat monitoring invention, per a Bloomberg report.
Apple also faced a class action lawsuit in 2019, claiming that the company’s Siri voice assistant violated customer privacy by recording users without their consent, per a Business Insider report.
Moreover, Apple had faced legal issues with Qualcomm (QCOM - Free Report) . However, the iPhone-maker settled with Qualcomm by making an undisclosed payment and inked a six-year global patent license agreement and a chipset supply agreement in April 2019.
Further, Apple has been accused of unfair practices and stifling competition in the music streaming space. In March 2019, a complaint was filed by music streaming giant Spotify (SPOT - Free Report) with the European Commission's antitrust regulators.
Wrapping Up
We believe that the removal of certain important features from Apple’s Watch may be a huge blow to the company. Thus, it is crucial for Apple to reach a settlement with Masimo, in case the lawsuit turns out to be legitimate.
Although Apple currently dominates the smartwatch segment, the loss of key features like blood oxygen monitoring system and heart rate detection through the light emitters could hurt its competitive position against the likes of Fitbit , Garmin and Samsung in the long run.
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Apple Faces Lawsuit for Alleged Violation of Masimo Patents
Apple (AAPL - Free Report) is facing a lawsuit for health monitoring features of Apple Watch, per a recent Bloomberg report.
Masimo and its subsidiary Cercacor have accused Apple of unduly exploiting their trademark technology in Apple Watch products, mainly to overcome performance issues.
Lodged with the U.S. District Court for the Central District of California, the suit alleges that Apple Watch, including the latest Apple Watch Series 4 and Series 5 models, leveraged technology covered by 10 Masimo patents. Apple has been accused of multiple infringements in these 10 different patents.
Notable among these is intellectual property detailing Apple Watch’s blood oxygen monitoring system and heart rate detection through light emitters. Masimo wishes to prevent any further usage of its patented inventions.
Apple has also been accused of hiring employees of Masimo for its own advantage, including former executive vice president of Medical Affairs Michael O’Reilly and Cercacor CTO, Marcelo Malini Lamego. Notably, Michael O’Reilly is currently the vice president of Apple’s health technology department.
Apple Inc. Price and Consensus
Apple Inc. price-consensus-chart | Apple Inc. Quote
Apple’s Increasing Legal Woes
The news comes at a time when Apple’s smartwatches are witnessing increased adoption in the market. Notably, per Strategy Analytics data, 6.8 million smartwatches were shipped by the company in third-quarter 2019, up 51% from the year-ago quarter figure of 4.5 million units.
Apple has been increasingly facing antitrust investigations and lawsuits over patents, user privacy and App Store-related lawsuits among others.
Last month, the tech giant was sued by a New York University cardiologist over Apple Watch’s use of his patented heartbeat monitoring invention, per a Bloomberg report.
Apple also faced a class action lawsuit in 2019, claiming that the company’s Siri voice assistant violated customer privacy by recording users without their consent, per a Business Insider report.
Moreover, Apple had faced legal issues with Qualcomm (QCOM - Free Report) . However, the iPhone-maker settled with Qualcomm by making an undisclosed payment and inked a six-year global patent license agreement and a chipset supply agreement in April 2019.
Further, Apple has been accused of unfair practices and stifling competition in the music streaming space. In March 2019, a complaint was filed by music streaming giant Spotify (SPOT - Free Report) with the European Commission's antitrust regulators.
Wrapping Up
We believe that the removal of certain important features from Apple’s Watch may be a huge blow to the company. Thus, it is crucial for Apple to reach a settlement with Masimo, in case the lawsuit turns out to be legitimate.
Although Apple currently dominates the smartwatch segment, the loss of key features like blood oxygen monitoring system and heart rate detection through the light emitters could hurt its competitive position against the likes of Fitbit , Garmin and Samsung in the long run.
Zacks Rank
Apple currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>